68 related articles for article (PubMed ID: 26680788)
21. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy).
Roncucci L; Pedroni M; Fante R; Di Gregorio C; Ponz de Leon M
Cancer Res; 1993 Aug; 53(16):3726-9. PubMed ID: 8339283
[TBL] [Abstract][Full Text] [Related]
22. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
23. Aberrant crypt foci in human colon carcinogenesis.
Dolara P; Caderni G; Lancioni L; Giannini A; Anastasi A; Fazi M; Castiglione G
Cancer Detect Prev; 1997; 21(2):135-40. PubMed ID: 9101074
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
[TBL] [Abstract][Full Text] [Related]
25. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
26. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases.
Yantiss RK; Goldman H; Odze RD
Mod Pathol; 2001 Sep; 14(9):869-75. PubMed ID: 11557782
[TBL] [Abstract][Full Text] [Related]
27. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
28. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
29. Colonic aberrant crypts in children with familial adenomatous polyposis.
Drut R
Int J Surg Pathol; 2007 Jul; 15(3):258-61. PubMed ID: 17652532
[TBL] [Abstract][Full Text] [Related]
30. Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy.
Takahashi H; Yamada E; Ohkubo H; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Nakajima A
World J Gastrointest Endosc; 2012 Dec; 4(12):561-4. PubMed ID: 23293726
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
33. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
[TBL] [Abstract][Full Text] [Related]
34. The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes.
Winkelmann I; Diehl D; Oesterle D; Daniel H; Wenzel U
Carcinogenesis; 2007 Jul; 28(7):1446-54. PubMed ID: 17347140
[TBL] [Abstract][Full Text] [Related]
35. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
Payne CM; Holubec H; Bernstein C; Bernstein H; Dvorak K; Green SB; Wilson M; Dall'Agnol M; Dvorakova B; Warneke J; Garewal H
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211
[TBL] [Abstract][Full Text] [Related]
36. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa.
Gianani R; Jarboe E; Orlicky D; Frost M; Bobak J; Lehner R; Shroyer KR
Hum Pathol; 2001 Jan; 32(1):119-25. PubMed ID: 11172305
[TBL] [Abstract][Full Text] [Related]
37. Identification of mucin depleted foci in the human colon.
Femia AP; Giannini A; Fazi M; Tarquini E; Salvadori M; Roncucci L; Tonelli F; Dolara P; Caderni G
Cancer Prev Res (Phila); 2008 Dec; 1(7):562-7. PubMed ID: 19139006
[TBL] [Abstract][Full Text] [Related]
38. Different genetic susceptibility to aberrant crypts and colon adenomas in mice.
Moen CJ; van der Valk MA; Bird RP; Hart AA; Demant P
Cancer Res; 1996 May; 56(10):2382-6. PubMed ID: 8625315
[TBL] [Abstract][Full Text] [Related]
39. Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenyl.
Feng Y; Wagner RJ; Fretland AJ; Becker WK; Cooley AM; Pretlow TP; Lee KJ; Hein DW
Cancer Res; 1996 Feb; 56(3):527-31. PubMed ID: 8564966
[TBL] [Abstract][Full Text] [Related]
40. Angiogenic switch in earliest stages of human colonic tumorigenesis.
Shpitz B; Gochberg S; Neufeld D; Grankin M; Buklan G; Klein E; Bernheim J
Anticancer Res; 2003; 23(6D):5153-7. PubMed ID: 14981982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
